Enara Bio
Latest round
- Series B
Last raised
- Sep 2024
Total raised
- $50M
Investors
- 6
About Enara Bio
Enara Bio Ltd.Founded in 2016 in Oxford, UK, Enara Bio Ltd. specializes in cancer immunotherapy. Enara Bio specializes in the development of cancer immunotherapies that target a novel class of cancer-specific targets known as Dark Antigens. Their primary technology platform, EDAPT®, integrates multifaceted approaches including bioinformatics, immunopeptidomics, target validation, and immunology to identify and leverage previously uncharted genomic dark matter.49 mn. The company is expected to focus on expanding its market reach and enhancing its therapeutic offerings. Specific new products are under development, although further details on release dates and targeted market expansions are yet to be disclosed.
Who invested in Enara Bio
6 investors across 2 rounds
See all investors in Enara Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enara Bio
Who invested in Enara Bio?
Enara Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enara Bio raised?
Enara Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Enara Bio last raise money?
Enara Bio's most recent round on record is a Series B, in Sep 2024.
What does Enara Bio do?
Enara Bio is a biotechnology company.
Where is Enara Bio headquartered?
Enara Bio is headquartered in Oxford, UK.
Which VCs invest in companies like Enara Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Enara Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Enara Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.